Anaemia during pregnancy is a major public health problem throughout the world, particularly in the developing countries. According to WHO, prevalence of anaemia in pregnant women is estimated as 14 per cent in developed and 51 percent in developing countries. In India the prevalence is 65-75 percent. Acharya Kashyapa explained that like other disorders Samprapti of Pandu is also similar in Garbhini. So all narration mentioned in Ayurvedic classics regarding Pandu is applicable to Garbhini- Pandu. In the present study total 37 patients were recruited under the study and distributed into two groups Group-A (Draksha ghrita) and Group-B (Lakshmana lauha). After completion of trial 30 patients data was only available for assessment and 07 patients were dropped out from the study due to their irregular follow-up. On analysis of results, none of the patient has showed excellent relief. 10.00% and 30.00% patient has showed moderate relief in group A & B respectively. 06.00% and 10.00% patient in A and B group showed marked relief while 06.66% and 00.00% patient in has showed mild relief in A and B group and also the 26.66% and 16.66% patient has showed no relief. When the two groups A and B were compared with each other, the percentage of relief is found higher in group B, so it implies that group B is more clinically significant than group A. Overall conclusion of this study is that Draksha Gritha and Lakshmana lauha both drugs are effective, but Lakshmana lauha is comparatively better to cure the Subjective and Objective parameter of Garbhini Pandu.
Cervical erosion is the commonest causes of vaginal discharge in females, where ectocervix is covered by columnar epithelium, that means natural squamous epithelium is later replaced by columnar epithelium and appears like a Karnikakara granthi or Vrana depending upon the chronicity. The condition of cervical erosion is commonly treated in contemporary system of medicine with invasive therapies such as electric cauterization, cryosurgery etc. Kshara karma is a minimal invasive procedure that helps to destroy the ectopic columnar epithelium. So in the present study, a 40 year old woman diagnosed with cervical erosion (Karnini yonivyapad) was treated with Kshara karma using Apamarga Pratisarainiya kshara for 3 sittings each on alternate days for two cycles, starting from fifth day of the menstruation. After treatment significant reduction in the extent of cervical erosion was observed and the patient got relief in associated complaints. From this case study, it can be concluded that Kshara karma with Apamarga pratisaraniya kshara may be used as a safe and economical option for treating the cervical erosion.
Jeevanti is the drug having Rasayana, Jeevaniya/ vitalizer, Vaya Sthaapana, Vrishya, Stanyajanana, Balya, and Anulomana properties. Acharya Charaka on the basis of its pharmacological action, and categorized under Jeevaniya Gana, Madhura Skandha, vayasthapana, etc. Acharya Vaghbhata has clarified its uses during pregnancy in Garbhini Paricharya. Ayurveda, Vedic science considered this state as Garbhini and various Acharyas has given their very own rituals known as Garbhini Paricharya. It has been practiced and tested from century which deals with the both maternal and fetal wellbeing but evidence is the most important fact for today’s era, hence, various drugs are being studied to know their efficacy and safety during pregnancy. Rasayana drugs have health restorative action which prevents Garbhini and Garbha from various infections and other complications. As well as, it improves strength of fetus by improving fetal nourishment through proper formation of Rasa dhatu. This conceptual study will put limelight on the importance of Rasayana drug i.e., Jeevanti in Garbhini Paricharya along with its benefits to Fetal nourishment and maternal wellbeing.
Primary dysmenorrhoea can be correlated with Kashtartava which is characterized by painful menstruation. According to Ayurveda, pain is an indication of Vata Vikriti – ‘Na hi vaatadrite Shoolam’. Apana Vayu has been given prime importance in Gynecological disorders. Normal menstruation is the function of the Apanavata, so painful menstruation is considered as Apanavatadushti. Vyana Vata has control over the muscles which brings about actions such as contraction, relaxation, extension, flexion etc. According to Acharya Charaka, Vata plays a key role in all types of Yoni Roga. As Vata is the main causative factor, it should be treated first. According to Acharya Vagbhata all measures capable of suppressing Vata are indicated. Till date, no successful advances have been made in the management of Primary dysmenorrhoea by conventional medicine. The best evidence-based treatments are NSAIDs and hormonal contraceptives but they have a lot of side effects. Owing to the gravity of the situation, need is felt for search of safe/more effective, palatable oral dosage forms to reduce pain during menstrual period. A systematic review of studies in developing countries performed by Harlow and Campbell has revealed that about 25-50% of adult women and about 75% of adolescents experience pain during menstruation. It is a randomized comparative clinical trial with 30 patients fulfilling the inclusion criteria were selected for the trial. The selected patients were randomly divided into 2 groups, 15 patients each. The duration of treatment was from 7th day due date of menstrual cycle to next menstrual cycle for 60 days. The assessment was done after each cycle on 5th day of cycle and follow-up for the next menstrual cycle. The test of significance showed that the efficacy of Hingvadi churna is more than Rajahpravartini vati in Kashtartava.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.